Location History:
- Köln, DE (2013 - 2014)
- Cologne, DE (2008 - 2020)
Company Filing History:
2 out of 709 
1 out of 2 
1 out of 1 
Years Active: 2008-2020
Title: Ralph Markus Wirtz: Innovator in Cancer Research
Introduction
Ralph Markus Wirtz is a distinguished inventor based in Köln, Germany. With an impressive portfolio of seven patents, he has made significant contributions to the field of cancer research, particularly in the development of methods aimed at improving patient treatment outcomes.
Latest Patents
Two of his most recent patents highlight his innovative work. Firstly, he developed methods and kits for the molecular subtyping of tumors. This invention provides an in vitro method for identifying the molecular subtype of a tumor in cancer patients and stratifying them for appropriate treatment. The kits he created are instrumental in this identification process.
Secondly, Wirtz's patent for predicting therapy responsiveness in basal-like tumors is groundbreaking. This invention pertains to analyzing a patient's clinical response to various treatment modalities. It involves several steps, including obtaining a biological sample, determining gene expression levels, and predicting therapeutic success based on comparative outcomes. This method holds promise for enhancing treatment personalization in oncology.
Career Highlights
Throughout his career, Ralph Markus Wirtz has worked with notable organizations, including Siemens Healthcare Diagnostics GmbH. His work in these institutions has positioned him as a leader in his field, contributing to innovations that bridge the gap between molecular research and clinical application.
Collaborations
Wirtz has collaborated with distinguished professionals, including Guido Hennig and Kerstin Bohmann. These collaborations have fostered an environment of innovation and shared knowledge, further advancing his research and patents.
Conclusion
Ralph Markus Wirtz stands out as a prominent figure in cancer research with significant contributions that aim to personalize treatment for patients. His patents not only represent individual achievements but also reflect his commitment to improving healthcare outcomes through innovative scientific methods.